Adamax: Dosage, Protocol, and Research Guide
Enhanced version of Semax with improved stability and potency
Mechanism
Increases BDNF expression, modulates neurotransmitters, enhances cognitive function and neuroprotection
Protocol at a glance
| Starting dose | 100mcg |
|---|---|
| Maintenance dose | 200-300mcg |
| Maximum dose | 300mcg |
| Frequency | 1-2x daily |
| Typical duration | 4-8 weeks |
| Route | Intranasal |
| Injection site | Nasal |
| Timing | Morning and afternoon |
Side effects
- Mild nasal irritation
- Potential overstimulation
Contraindications
- Acute psychosis
- Severe hypertension
Protocol notes
- More potent than regular Semax
- Improved stability
- Enhances focus and memory
- May increase anxiety in sensitive individuals
- Cycle to prevent tolerance
Frequently asked questions
What is Adamax and how does it work?
Adamax is an enhanced analog of Semax, a peptide derived from ACTH(4-10), designed specifically for cognitive research. It functions by increasing BDNF (brain-derived neurotrophic factor) expression and modulating neurotransmitter systems in the brain. BDNF is essential for neuroplasticity and the formation of new neural connections. By enhancing BDNF signaling through trkB receptors and neurotransmitter modulation, Adamax supports cognitive function and neuroprotection. The mechanism makes it particularly valuable for research into cognitive enhancement, memory consolidation, and neuronal resilience.
What are the dosing guidelines for Adamax?
Adamax dosing for research protocols typically begins at 100mcg as a starting dose, escalates to a maintenance range of 200-300mcg daily, with a maximum dose ceiling of 300mcg. Administration is intranasal, with frequency of 1-2x daily dosing. Timing is typically split between morning and afternoon to align with cognitive performance windows. Research cycles typically run 4-8 weeks in duration. After completing a cycle, a washout period is recommended to prevent tolerance development before initiating another research protocol.
How does Adamax differ from regular Semax?
Adamax is an enhanced version of standard Semax with three primary advantages: significantly improved chemical stability, which reduces degradation during storage and handling; greater potency, meaning lower doses achieve equivalent or superior effects; and a more favorable side effect profile in most research applications. While both peptides increase BDNF expression and enhance cognitive function, Adamax's improved formulation reduces variability in research outcomes and extends shelf-life, making it more practical for sustained research protocols.
Why is cycling important with Adamax?
Cycling Adamax—alternating periods of use with washout periods—is critical to prevent tolerance development. With prolonged continuous use, receptor sensitivity decreases and the peptide's cognitive effects may diminish. A standard research approach involves 4-8 week cycles followed by sufficient washout time before re-initiating use. This cycling strategy maintains efficacy across multiple protocols and ensures consistent BDNF upregulation and cognitive enhancement. Cycling also allows the brain's neurotransmitter systems to reset and restabilize.
What are the side effects of Adamax?
The most common side effect reported in research settings is mild nasal irritation at the administration site due to intranasal delivery. More significant potential adverse effects include overstimulation, particularly at higher doses (approaching the 300mcg maximum) or with frequent dosing. Some sensitive individuals may experience increased anxiety. Adamax should be avoided in individuals with acute psychosis or severe hypertension, as its stimulatory effects could exacerbate these conditions. Starting at the lowest effective dose and monitoring individual response is recommended.
Is Adamax legal for research use?
Adamax's legal status varies by jurisdiction. It is not FDA-approved for human use and is classified as a research peptide. In many countries, research peptides are permitted for scientific study and quality research purposes but are not approved for clinical or commercial sale as pharmaceuticals. Before obtaining or using Adamax, verify the legal status in your specific jurisdiction, as regulations differ significantly between countries and regions. All use should be conducted under appropriate medical supervision where required by local law.
Can Adamax be stacked with other compounds?
Research on Adamax stacking remains limited in published literature. While some researchers explore combining peptides with similar mechanisms or complementary targets, stacking decisions should be made with careful consideration of potential interactions. The stimulatory nature of Adamax means combining it with other CNS stimulants carries inherent risks. Any stacking protocol should be discussed with a qualified physician familiar with peptide research and the specific compounds under consideration, as individual biochemistry and safety profiles vary substantially.
What lab markers should be monitored during Adamax research?
Research on specific lab marker monitoring protocols for Adamax remains limited. However, given Adamax's mechanism of BDNF upregulation and neurotransmitter modulation, baseline assessment of cardiovascular function (particularly given hypertension contraindications) and psychological status is advisable before initiating a research protocol. Standard blood work to establish baseline metabolic and endocrine function is prudent practice. Because research on Adamax-specific biomarkers is ongoing, consultation with a physician experienced in peptide research can help determine appropriate monitoring for individual protocols.
More Cognitive & Nootropic peptides · All peptide guides · Free dose calculator
Educational reference only — not medical advice. Work with a qualified clinician.